July 24, 2018
After a contentious hearing last week, federal prosecutors charging several former Insys Therapeutics Inc. executives with conspiring to bribe doctors so they'd prescribe the company's fentanyl spray tried to explain the racketeering charges to a puzzled Massachusetts federal judge and promised a new, streamlined indictment in a memorandum filed Tuesday morning.
July 17, 2018
A Massachusetts federal judge on Tuesday appeared befuddled by the government's Racketeer Influenced and Corrupt Organizations Act indictment charging former Insys Therapeutics Inc. executives with multiple schemes to bribe doctors to prescribe the company's pricey fentanyl spray, saying the allegations are confusing and fail to establish a common link in the alleged conspiracy.
June 12, 2018
Federal prosecutors late Monday blasted an attempt by former executives at Insys Therapeutics Inc. to get more details about charges that they bribed doctors to boost sales of their fentanyl spray, saying the executives have more than enough information from the complaint and discovery.
May 22, 2018
Former executives at Insys Therapeutics Inc. blasted "inflammatory" drug-enterprise charges against them on Monday in a bid to dismiss a lengthy indictment claiming they bribed doctors to prescribe the company's expensive fentanyl spray, calling the allegations "ugly insinuations about lawful business practices."
January 18, 2018
Former executives at Insys Therapeutics Inc. charged with plotting to bribe fentanyl prescribers notched a quick win on evidence access Thursday at a Boston hearing that grew tense after defense counsel surprised a leading federal prosecutor with last-minute motions.
January 01, 2018
The year ahead promises to bring several high-profile cases to Massachusetts as the office of newly appointed U.S. Attorney Andrew Lelling gets ready to try consequential matters involving public corruption and the opioid crisis, while the U.S. Supreme Court considers petitions over a Native American tribe's bid to bring casino gambling to Martha's Vineyard.
November 16, 2017
Insys Therapeutics Inc. founder John N. Kapoor pled not guilty on Thursday to orchestrating a national scheme to bribe doctors to needlessly prescribe his company's unique and powerful opioid painkiller that is sprayed under the tongue.
October 31, 2017
John N. Kapoor, the founder of Insys Therapeutics Inc., has resigned from the company's board of directors after he was charged with racketeering and fraud for allegedly bribing doctors who prescribed a spray version of the opioid fentanyl to patients who didn't necessarily have cancer pain.
October 26, 2017
John Kapoor, the founder and chairman of scandal-wracked Insys Therapeutics Inc., was arrested and charged with racketeering and fraud on Thursday for allegedly bribing doctors to prescribe a powerful fentanyl-based painkiller for off-label uses, joining six other Insys officials who have been charged.
September 12, 2017
A Massachusetts federal judge on Tuesday set an Oct. 15, 2018, trial date for six former Insys Therapeutics Inc. executives and managers accused of bribing doctors to prescribe a spray version of the opioid fentanyl intended to treat cancer pain, often to patients without cancer.